We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Union Pacific
UNP
$176B
| $27M | 0.25% |
109,913
+39,360
| +56% | +$9.69M |
|
127
Vaxcyte
PCVX
$8.05B
| $26.9M | 0.25% |
393,704
+353
| +0.1% | +$24.4K |
|
128
Encompass Health
EHC
$11B
| $26.9M | 0.25% |
+325,501
| New | +$23.8M |
|
129
Core & Main
CNM
$8.66B
| $26.7M | 0.25% |
465,800
-125,939
| -21% | -$5.77M |
|
|
AEL
130
DELISTED
American Equity Investment Life Holding Company
AEL
| $26.6M | 0.24% |
472,813
+51,310
| +12% | +$2.85M |
|
131
Viper Energy
VNOM
$8.25B
| $26.5M | 0.24% |
+689,922
| New | +$23.3M |
|
132
W.R. Berkley
WRB
$26.8B
| $26.5M | 0.24% |
+449,823
| New | +$24.3M |
|
133
Charter Communications
CHTR
$17.9B
| $26.3M | 0.24% |
90,553
+36,769
| +68% | +$11.8M |
|
134
Bentley Systems
BSY
$10.9B
| $26.2M | 0.24% |
+501,383
| New | +$25.2M |
|
135
TripAdvisor
TRIP
$1.65B
| $25.9M | 0.24% |
+931,344
| New | +$22.6M |
|
136
Texas Roadhouse
TXRH
$13.7B
| $25.8M | 0.24% |
166,812
+19,067
| +13% | +$2.61M |
|
137
Cencora
COR
$62.5B
| $25.6M | 0.24% |
+105,238
| New | +$24.2M |
|
138
Reinsurance Group of America
RGA
$15.6B
| $25.5M | 0.23% |
+132,291
| New | +$23.1M |
|
|
CERE
139
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $25.4M | 0.23% |
600,001
+394,192
| +192% | +$16.6M |
|
|
AVDL
140
DELISTED
Avadel Pharmaceuticals
AVDL
| $25.3M | 0.23% |
1,500,524
-351,888
| -19% | -$5.24M |
|
141
Immatics
IMTX
$1.3B
| $25M | 0.23% |
2,373,987
+303,904
| +15% | +$3.54M |
|
|
SEE
142
DELISTED
Sealed Air
SEE
| $23.6M | 0.22% |
633,248
-198,724
| -24% | -$7.13M |
|
143
Organon & Co
OGN
$3.56B
| $23.5M | 0.22% |
+1,252,505
| New | +$21.5M |
|
144
Crown Holdings
CCK
$13.2B
| $23.4M | 0.22% |
295,637
-46,206
| -14% | -$3.78M |
|
145
Exelixis
EXEL
$14.2B
| $23.4M | 0.22% |
987,094
| – | – |
|
|
SBOW
146
DELISTED
SilverBow Resources, Inc.
SBOW
| $23.3M | 0.21% |
683,144
-290,775
| -30% | -$8.45M |
|
147
CG Oncology
CGON
$6.39B
| $23.1M | 0.21% |
+525,199
| New | +$21.4M |
|
|
NWLI
148
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $23M | 0.21% |
46,801
+6,801
| +17% | +$3.3M |
|
149
Capri Holdings
CPRI
$1.9B
| $22.8M | 0.21% |
503,666
-56,335
| -10% | -$2.68M |
|
150
Zentalis Pharmaceuticals
ZNTL
$342M
| $22.6M | 0.21% |
1,437,026
+33,473
| +2% | +$460K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.